There have been no injuries or deaths associated with the recall.
“A reduced-energy electrical shock may fail to correct an irregular heartbeat or may cause an irregular heartbeat,” the FDA said in a news release. A software update is currently available, a Medtronic spokesperson told Becker’s.
The Minneapolis-based company recalled four products: Cobalt XT, Cobalt, and Crome Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillators.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
